New Blood-Cleansing method boosts transplant success in High-Risk patients

This study looked at 50 patients who needed a stem cell transplant from a partially matched donor but had antibodies that could attack the donor cells. Before transplant, they received a blood purification treatment called protein A immunoadsorption to remove those antibodies, sometimes along with other drugs. The goal was to see if this approach helps the new stem cells take hold and reduces complications like graft failure or infection.